mediate (+ +) and high (+ + +). Afterwards, quantitation was performed on epithelial cells of at least 7 lobules in each case. Grade 1 corresponded to less than 10% of positive cells, grade 2 to 15-35%, and grade 3 to over 40%. Results were expressed as mean 2SEM of percentage of positive cells.
bcl-2 expression in the spectrum of preinvasive breast lesions
β Scribed by Kalliopi P. Siziopikou; John E. Prioleau; Jay R. Harris; Stuart J. Schnitt
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 800 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
BACKGROUND.
The bcI-2 gene encodes for a protein that blocks apoptosis. Although the Ocl-2 protein has been identified in some invasive breast cancers, its expression in preinvasive breast lesions has not been well characterized.
METHODS.
We studied bcl-2 expression using immunohistochemistry in cases of normal breast tissue (n = lo), ductal hyperplasia ( t i = 181, atypical ductal hyperplasia (ADH) (n = lo), atypical lobular hyperplasia/lobular carcinoma in situ (lobular neoplasia, LN) (n = lo), and ductal carcinoma in situ (DCIS) (n = 42). We also related bcl-2 expression to p53 expression in these lesions because the p53 gene is altered in many invasive breast cancers and is also involved in the regulation of apoptosis.
π SIMILAR VOLUMES
The expression of the pro-apoptotic proteins (Bax, Bak) and anti-apoptotic proteins (Bcl-2, Bcl-X, Mcl-1) was studied by immunohistochemistry in 110 invasive ductal breast carcinomas. The results were correlated with tumour grade, expression of oestrogen receptor (ER) and p53 protein, and the apopto